Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis

Stinne Ravn Greisen; H J Moller; Kristian Stengaard-Pedersen; M L Hetland; Kim Hørslev-Petersen; A Jørgensen; M Hvid; Bent Winding Deleuran

Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis

Stinne Ravn Greisen, H J Moller, Kristian Stengaard-Pedersen, M L Hetland, Kim Hørslev-Petersen, A Jørgensen, M Hvid, Bent Winding Deleuran

57 Citations (Scopus)

Abstract

To investigate the expression of the soluble form of the resident macrophage marker CD163 (sCD163) and its association with core parameters for disease activity, including radiographic progression in early rheumatoid arthritis (RA).

Original language	English
Journal	Clinical and Experimental Rheumatology
Volume	29
Issue number	4
Pages (from-to)	689-92
Number of pages	4
ISSN	0392-856X
Publication status	Published - 2011
Externally published	Yes

Keywords

Aged
Aged, 80 and over
Antigens, CD
Antigens, Differentiation, Myelomonocytic
Antirheumatic Agents
Arthritis, Rheumatoid
Biological Markers
Blood Sedimentation
C-Reactive Protein
Denmark
Disease Progression
Double-Blind Method
Drug Therapy, Combination
Early Diagnosis
Female
Humans
Longitudinal Studies
Macrophages
Male
Middle Aged
Osteoarthritis
Predictive Value of Tests
Receptors, Cell Surface
Synovial Fluid
Time Factors
Treatment Outcome

Cite this

@article{79154b6f5e41416b914881177080abd4,

title = "Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis",

abstract = "To investigate the expression of the soluble form of the resident macrophage marker CD163 (sCD163) and its association with core parameters for disease activity, including radiographic progression in early rheumatoid arthritis (RA).",

keywords = "Aged, Aged, 80 and over, Antigens, CD, Antigens, Differentiation, Myelomonocytic, Antirheumatic Agents, Arthritis, Rheumatoid, Biological Markers, Blood Sedimentation, C-Reactive Protein, Denmark, Disease Progression, Double-Blind Method, Drug Therapy, Combination, Early Diagnosis, Female, Humans, Longitudinal Studies, Macrophages, Male, Middle Aged, Osteoarthritis, Predictive Value of Tests, Receptors, Cell Surface, Synovial Fluid, Time Factors, Treatment Outcome",

author = "Greisen, \{Stinne Ravn\} and Moller, \{H J\} and Kristian Stengaard-Pedersen and Hetland, \{M L\} and Kim H{\o}rslev-Petersen and A J{\o}rgensen and M Hvid and Deleuran, \{Bent Winding\}",

year = "2011",

language = "English",

volume = "29",

pages = "689--92",

journal = "Clinical and Experimental Rheumatology",

issn = "0392-856X",

publisher = "Clinical and Experimental Rheumatology S.A.S.",

number = "4",

}

TY - JOUR

T1 - Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis

AU - Greisen, Stinne Ravn

AU - Moller, H J

AU - Stengaard-Pedersen, Kristian

AU - Hetland, M L

AU - Hørslev-Petersen, Kim

AU - Jørgensen, A

AU - Hvid, M

AU - Deleuran, Bent Winding

PY - 2011

Y1 - 2011

N2 - To investigate the expression of the soluble form of the resident macrophage marker CD163 (sCD163) and its association with core parameters for disease activity, including radiographic progression in early rheumatoid arthritis (RA).

AB - To investigate the expression of the soluble form of the resident macrophage marker CD163 (sCD163) and its association with core parameters for disease activity, including radiographic progression in early rheumatoid arthritis (RA).

KW - Aged

KW - Aged, 80 and over

KW - Antigens, CD

KW - Antigens, Differentiation, Myelomonocytic

KW - Antirheumatic Agents

KW - Arthritis, Rheumatoid

KW - Biological Markers

KW - Blood Sedimentation

KW - C-Reactive Protein

KW - Denmark

KW - Disease Progression

KW - Double-Blind Method

KW - Drug Therapy, Combination

KW - Early Diagnosis

KW - Female

KW - Humans

KW - Longitudinal Studies

KW - Macrophages

KW - Male

KW - Middle Aged

KW - Osteoarthritis

KW - Predictive Value of Tests

KW - Receptors, Cell Surface

KW - Synovial Fluid

KW - Time Factors

KW - Treatment Outcome

UR - https://www.scopus.com/pages/publications/80055099776

M3 - Journal article

C2 - 21813065

SN - 0392-856X

VL - 29

SP - 689

EP - 692

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

IS - 4

ER -

Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis

Abstract

Keywords

Other files and links

Fingerprint

Cite this